Skip to content
Search

Latest Stories

'Pharmacy teams need enhanced clinical roles'

The Pharmacists’ Defence Association (PDA) has republished a three-year-old report which underscores the vital role of community pharmacists and pharmacy technicians in a 'modern NHS' amid speculations that the government is set to announce plans to enhance the role of community pharmacy teams.

PDA's 2019 report which "took three year to compile" highlighted significant empirical evidence and made recommendations to develop the roles of both community pharmacists and pharmacy technicians, and the skill mix required to meet patients’ needs.


It examined in detail the role of pharmacy technicians in community pharmacy.

The PDA still that pressure on the NHS can be managed much more effectively through the better use of pharmacists and pharmacy technicians. In the community pharmacy setting, it is evident that if the further development of the pharmacist’s role is to be facilitated and pharmacists are to become more patient facing in the future, an extended role and greater responsibility for pharmacy technicians is not only desirable, but ultimately it is essential.

The pharmacy minister in England, Maria Caulfield MP was recently quoted as saying the Westminster government was “…looking at developing the role of community pharmacy teams, because it is not just the pharmacist who has clinical knowledge and skills. We are working in a number of areas to upskill the whole community pharmacy team so that they can deliver more and use their skills in a better way.”

In anticipation of such announcements, the PDA reiterated that it is essential, when skill mix is being considered, that patient safety standards be maintained.

Pharmacy technicians are a vitally important group of practitioners in the modern NHS; however their roles and responsibilities must not be confused with those of pharmacists. The public must never be confused or misled into thinking that they are dealing with a pharmacist, when they are actually dealing with a pharmacy technician.

The Technicians report covers many considerations including comparisons to the role of technicians in other areas of healthcare and internationally.  The report explains the difference between a technician and a professional role.

One significant concern raised in the report was that 73 per cent of those on the register of pharmacy technicians (as at April, 2017) had been admitted onto the register through ‘grandparenting’ arrangements, and the GPhC held no records of any assessments having been conducted as to the suitability of the qualifications which were relied upon during the grandparenting process. Though this figure has since reduced to 53 per cent (at 31 March 2022) of registrant technicians, the above still applies for the majority of the Technician workforce.

Overall, the report recommended and described a way forward which could be embraced, to:

  • Unify pharmacists and pharmacy technicians behind a common vision and purpose, based on shared interests and mutual benefit.
  • Develop more rewarding, fulfilling roles for both groups, including enhanced clinical roles, which make more appropriate use of their respective skills.
  • Establish a symbiotic, complementary and effective skill mix model in community pharmacy.
  • Create rewarding career frameworks, supported by skills and salary escalators and appropriate remuneration.
  • Enhance patient care and safety, improve governance and regulation, develop the UK healthcare infrastructure and reduce the burden both on community pharmacy and other areas of the NHS such as GP surgeries and secondary care.

The PDA hopes that any decisions about future skill mix and the roles of pharmacists and technicians will have considered the factors covered in the report and will have considered how the above points can be delivered.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less